{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:54:36Z","timestamp":1791320076506,"version":"4.3.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019657","name":"Cardiovascular Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019657","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ahj.2023.05.017","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T02:07:16Z","timestamp":1685671636000},"page":"83-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Preventive PCI or medical therapy alone for vulnerable atherosclerotic coronary plaque: Rationale and design of the randomized, controlled PREVENT trial"],"prefix":"10.1016","volume":"264","author":[{"given":"Jung-Min","family":"Ahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do-Yoon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pil Hyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Keun","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won-Jang","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Wook","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ok","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Ho","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Shiomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul Hsien Li","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo-Yong","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Ho","family":"Her","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bong-Ki","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Hoon","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyuk","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jei Keon","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Smyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg W.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6643-0239","authenticated-orcid":false,"given":"Duk-Woo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Jung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2023.05.017_bib0001","first-page":"e9349","article-title":"Global epidemiology of ischemic heart disease: results from the global burden of disease study","volume":"12","author":"Khan","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.ahj.2023.05.017_bib0002","series-title":"The ESC Textbook of Cardiovascular Medicine","first-page":"1214","article-title":"Epidemiology of acute coronary syndromes","author":"Bueno","year":"2018"},{"key":"10.1016\/j.ahj.2023.05.017_bib0003","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2023.05.017_bib0004","first-page":"e18","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"145","author":"Lawton","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.05.017_bib0005","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.jcin.2020.05.040","article-title":"Influence of anatomical and clinical characteristics on long-term prognosis of FFR-guided deferred coronary lesions","volume":"13","author":"Cho","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2023.05.017_bib0006","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008355","article-title":"Two-year outcomes after deferral of revascularization based on fractional flow reserve: the J-CONFIRM registry","volume":"13","author":"Kuramitsu","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2023.05.017_bib0007","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/eurheartj\/ehu412","article-title":"Risk model for estimating the 1-year risk of deferred lesion intervention following deferred revascularization after fractional flow reserve assessment","volume":"36","author":"Depta","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2023.05.017_bib0008","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1016\/j.jacc.2020.10.021","article-title":"Impact of plaque burden versus stenosis on ischemic events in patients with coronary atherosclerosis","volume":"76","author":"Mortensen","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.05.017_bib0009","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1093\/eurheartj\/ehaa227","article-title":"Vulnerable plaques and patients: state-of-the-art","volume":"41","author":"Tomaniak","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2023.05.017_bib0010","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.jcmg.2011.06.006","article-title":"The reality of vulnerable plaque detection","volume":"4","author":"Stone","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.ahj.2023.05.017_bib0011","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1002358","article-title":"A prospective natural-history study of coronary atherosclerosis","volume":"364","author":"Stone","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2023.05.017_bib0012","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jcmg.2011.05.005","article-title":"Association between IVUS findings and adverse outcomes in patients with coronary artery disease: the VIVA (VH-IVUS in Vulnerable Atherosclerosis) study","volume":"4","author":"Calvert","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.ahj.2023.05.017_bib0013","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/eurheartj\/eht484","article-title":"In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome: results of the ATHEROREMO-IVUS study","volume":"35","author":"Cheng","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2023.05.017_bib0014","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/S0140-6736(19)31794-5","article-title":"Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort study","volume":"394","author":"Waksman","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2023.05.017_bib0015","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0140-6736(21)00249-X","article-title":"Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study","volume":"397","author":"Erlinge","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2023.05.017_bib0016","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.jacc.2017.03.556","article-title":"Clinical significance of lipid-rich plaque detected by optical coherence tomography: a 4-year follow-up study","volume":"69","author":"Xing","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.05.017_bib0017","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/eurheartj\/ehz520","article-title":"Relationship between coronary plaque morphology of the left anterior descending artery and 12 months clinical outcome: the CLIMA study","volume":"41","author":"Prati","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2023.05.017_bib0018","doi-asserted-by":"crossref","first-page":"945","DOI":"10.4244\/EIJV8I8A144","volume":"8","author":"Wykrzykowska","year":"2012","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ahj.2023.05.017_bib0019","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.jacc.2020.09.547","article-title":"Percutaneous coronary intervention for vulnerable coronary atherosclerotic plaque","volume":"76","author":"Stone","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.05.017_bib0020","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8821525","article-title":"Pre-emptive OCT-guided angioplasty of vulnerable intermediate coronary lesions: results from the prematurely halted PECTUS-trial","volume":"2020","author":"Mol","year":"2020","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.ahj.2023.05.017_bib0021","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1161\/CIRCULATIONAHA.109.874057","volume":"120","author":"Rod\u00e9s-Cabau","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.05.017_bib0022","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/S0735-1097(01)01175-5","volume":"37","author":"Mintz","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.05.017_bib0023","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4244\/EIJV5I2A29","article-title":"Tissue characterisation using intravascular radiofrequency data analysis: recommendations for acquisition, analysis, interpretation and reporting","volume":"5","author":"Garcia-Garcia","year":"2009","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ahj.2023.05.017_bib0024","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.jacc.2011.09.079","article-title":"Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation","volume":"59","author":"Tearney","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.05.017_bib0025","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1016\/j.jacc.2017.09.1106","article-title":"Effect of technique on outcomes following bioresorbable vascular scaffold implantation: analysis from the ABSORB trials","volume":"70","author":"Stone","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.05.017_bib0026","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1161\/CIR.0000000000000095","article-title":"2014 ACC\/AHA\/AATS\/PCNA\/SCAI\/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease","volume":"130","author":"Fihn","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.05.017_bib0027","first-page":"e1046","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American college of cardiology\/American Heart association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.05.017_bib0028","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2023.05.017_bib0029","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1161\/01.CIR.79.4.733","article-title":"Circadian variation and triggers of onset of acute cardiovascular disease","volume":"79","author":"Muller","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.05.017_bib0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jacc.2010.04.012","article-title":"Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study","volume":"56","author":"Pijls","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.05.017_bib0031","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1093\/eurheartj\/ehv452","article-title":"Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial","volume":"36","author":"Zimmermann","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2023.05.017_bib0032","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1161\/CIRCULATIONAHA.116.024433","article-title":"fractional flow reserve and cardiac events in coronary artery disease: data from a prospective IRIS-FFR registry (Interventional Cardiology Research Incooperation Society Fractional Flow Reserve)","volume":"135","author":"Ahn","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.05.017_bib0033","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/j.jacc.2019.02.060","article-title":"Prognostic implications of plaque characteristics and stenosis severity in patients with coronary artery disease","volume":"73","author":"Lee","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.05.017_bib0034","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.jcin.2018.05.029","article-title":"Safety of the deferral of coronary revascularization on the basis of instantaneous wave-free ratio and fractional flow reserve measurements in stable coronary artery disease and acute coronary syndromes","volume":"11","author":"Escaned","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2023.05.017_bib0035","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0140-6736(08)60415-8","article-title":"A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial","volume":"371","author":"Ormiston","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2023.05.017_bib0036","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa1614954","article-title":"Bioresorbable scaffolds versus metallic stents in routine PCI","volume":"376","author":"Wykrzykowska","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2023.05.017_bib0037","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1016\/j.jacc.2017.10.010","article-title":"3-year clinical outcomes with everolimus-eluting bioresorbable coronary scaffolds: the ABSORB III trial","volume":"70","author":"Kereiakes","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.05.017_bib0038","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jcin.2020.05.036","article-title":"Stenting \"vulnerable\" but fractional flow reserve-negative lesions: potential statistical limitations of ongoing and future trials","volume":"14","author":"Zimmermann","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2023.05.017_bib0039","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.jacc.2013.08.720","article-title":"Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI)","volume":"62","author":"Moussa","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.05.017_bib0040","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth Universal Definition of Myocardial Infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.05.017_bib0041","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.05.017_bib0042","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1161\/CIRCULATIONAHA.117.029289","article-title":"Standardized end point definitions for coronary intervention trials: the academic research consortium-2 consensus document","volume":"137","author":"Garcia-Garcia","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.05.017_bib0043","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870323001345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870323001345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:10:44Z","timestamp":1757571044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870323001345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":43,"alternative-id":["S0002870323001345"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2023.05.017","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preventive PCI or medical therapy alone for vulnerable atherosclerotic coronary plaque: Rationale and design of the randomized, controlled PREVENT trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2023.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}